Skip to content
VialUnits

Retatrutide 30 mg vial: water, concentration and units

A 30 mg Retatrutide vial with 2 mL of water is 15 mg/mL, so one unit on a U-100 syringe holds 150 mcg and 10 units hold 1.5 mg.

Other water volumes and syringes are below. Unit conversion only.

Quick reference

Retatrutide 30 mg vial at common water volumes
Water addedConcentration1 unit (U-100)10 units
1 mL30 mg/mL300 mcg3 mg
2 mL15 mg/mL150 mcg1.5 mg
3 mL10 mg/mL100 mcg1 mg
mg
mL

Your number. This site never suggests one.

Concentration

15mg/mL

Enter an amount to see the syringe reading.

0102030405060708090100
U-100, 1 mL (100 units): empty. Enter values to see the reading.

What each reading holds

Units (U-100)mLHolds
100.11.5 mg
250.253.75 mg
500.57.5 mg
100115 mg
Work backwards: how much water?

Pick how many units you want your amount to read, and this gives the water volume that produces that concentration for Retatrutide.

units

Enter the vial amount and the amount to measure first.

Math only. Check every number against your vial label.

By [Author name]. Licensed pharmacist review: pending. Last updated .

The math for this vial

  1. Concentration: 30 mg ÷ 2 mL = 15 mg/mL (15,000 mcg/mL).
  2. Volume of one U-100 unit: 1 ÷ 100 = 0.01 mL.
  3. Mass in one unit: 15,000 mcg/mL × 0.01 mL = 150 mcg.
  4. The whole vial is 200 U-100 units of solution, more than one 1 mL syringe holds.

On a U-40 syringe each unit is 0.025 mL, so each unit holds 2.5 times as much: 375 mcg at 2 mL. See U-100 vs U-40 units.

Unit chart

What common U-100 readings hold from a 30 mg vial, by water volume.

UnitsmL1 mL water2 mL water3 mL water
10.01300 mcg150 mcg100 mcg
50.051.5 mg750 mcg500 mcg
100.13 mg1.5 mg1 mg
200.26 mg3 mg2 mg
250.257.5 mg3.75 mg2.5 mg
500.515 mg7.5 mg5 mg
100130 mg15 mg10 mg

About this vial size

30 mg is the largest common Retatrutide vial. Across the water volumes above, one U-100 unit holds between 100 mcg (at 3 mL) and 300 mcg (at 1 mL). Compared with a 20 mg vial at the same water volume, it is 1.5 times as concentrated, so the same mass takes 0.67 times the units.

Vial sizes for retatrutide span a wide range, so the same volume of water gives very different concentrations. 2 mL in a 5 mg vial is 2.5 mg/mL; 2 mL in a 30 mg vial is 15 mg/mL, six times stronger. Re-check the vial size every time; it is the most common input mistake.

Storage and handling

  • No approved label exists for retatrutide, so there is no official storage or in-use stability data. Published stability data for reconstituted research material is also absent.
  • General lab practice for lyophilized peptides: store sealed vials cold and away from light; after reconstitution keep the vial refrigerated (2-8 °C), do not freeze it, and label it with the date and concentration.

Retatrutide is an investigational Eli Lilly drug in Phase 3 trials. It is not FDA-approved, cannot be legally compounded, and FDA has issued warning letters to online sellers of "research" retatrutide.

Retatrutide 30 mg vial questions

How much water goes in a 30 mg Retatrutide vial?

Any volume works; water only sets the concentration. 1 mL gives 30 mg/mL, 2 mL gives 15 mg/mL, 3 mL gives 10 mg/mL. Less water packs more mass into each syringe unit (harder to read precisely); more water spreads it out.

How many mcg are in one unit of a 30 mg vial?

On a U-100 syringe, one unit is 0.01 mL. With 1 mL of water, one unit holds 300 mcg; With 2 mL of water, one unit holds 150 mcg; With 3 mL of water, one unit holds 100 mcg.

How many units is 1 mg from a 30 mg vial?

At 1 mL of water, 1 mg is 3.3 units (0.033 mL). At 2 mL of water, 1 mg is 6.7 units (0.067 mL). At 3 mL of water, 1 mg is 10 units (0.1 mL). This is a unit conversion, not an amount to use.

Sources

  1. Eli Lilly: What to know about retatrutide
  2. Jastreboff AM et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. N Engl J Med. 2023
  3. Rosenstock J et al. Retatrutide for people with type 2 diabetes: a phase 2 trial. Lancet. 2023
  4. Coskun T et al. LY3437943, a novel triple GIP, GLP-1 and glucagon receptor agonist. Cell Metab. 2022
  5. PubChem: Retatrutide
  6. FDA warning letter to Peptide Partners LLC, #735063 (2026-08-24)
  7. WADA Prohibited List